Plain-English translation of NCT06980740 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial evaluates a new way of delivering expert cancer care called a "video tumor board" — where multiple skin cancer specialists review your case together and make treatment recommendations through video meetings. The study includes patients with melanoma and other serious skin cancers who are being treated at hospitals across Germany. Researchers want to see if this approach helps more patients benefit from specialist expertise, no matter where they live.
Currently, only some cancer patients can access expert team consultations because they may live far from major cancer centers. This study aims to remove that barrier by using video meetings so that specialized doctors can review and advise on skin cancer cases from anywhere.
You likely qualify if…
You likely don't qualify if…
If you qualify, your medical case will be presented to a team of skin cancer experts during a weekly video meeting called a tumor board. You may participate as a retrospective case (your medical records are reviewed) or a prospective case (your doctors follow your care going forward). Your treating physician will present your information to the specialist team, and you will receive their combined recommendations. You do not necessarily need to attend the video meeting yourself — your local doctor will handle the presentation and keep you informed of the recommendations.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Germany
Sponsor
University Hospital Muenster
Collaborators
Deutsche Krebshilfe e.V., Bonn (Germany), University Hospital, Bonn
Enrollment target
~300 participants
Started
May 2025
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Philipp Lenz, MD
Westdeutsches Tumorzentrum Münster, Universitätsklinikum Münster
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.